Of note, therapeutic targeting of TGFβ3 by anti-TGFβ3 antibody attenuated fibrosis in an animal model of fibrosis45, raising the possibility of selectively targeting TGFβ3 to prevent exuberant synovial tissue fibrosis in RA patients. The gene discussed is TGFB3; the disease is rheumatoid arthritis.